Article
Haptoglobin phenotype as a predictor of restenosis after percutaneous transluminal coronary angioplasty.
The American journal of cardiology - 1 Feb 2001
Roguin A, Hochberg I, Nikolsky E, Markiewicz W, Meisel S R, Hir J, Grenadier E, Beyar R, Levy A P
Abstract excerpt
We have demonstrated that a genetic polymorphism in the antioxidant protein haptoglobin is important in determining which patients develop restenosis after percutaneous transluminal coronary angioplasty. Knowledge of the haptoglobin phenotype may be useful in the assessment and utilization of new therapies to reduce restenosis, particularly in patients who are homozygous for the haptoglobin 2 allele.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.